Skip to main content
Clinical Trials/IRCT138904151179N4
IRCT138904151179N4
Completed
未知

Effect of raloxifen in post menopausal women with diabetic nephropathy

Zanjan Metabolic Diseases Research Center, Zanjan University of Medical Sciences0 sites50 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diabetic Nephropathy.
Sponsor
Zanjan Metabolic Diseases Research Center, Zanjan University of Medical Sciences
Enrollment
50
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Zanjan Metabolic Diseases Research Center, Zanjan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria : confirmed menopause (last period of the patient over the past year and FSH levels is more than 25mu/L, Age less than 70 years, confirmed albuminuria due to DM (ACR\> 30mg/gr)
  • Exclusion criteria: History of Treatment with estrogen or SERM in the past six months, a personal history of breast or Genicologic cancer, History of thrombotic disorders, GFR less than 30 mL/min, hypertriglyceridemia over than 400 mg/dl, Active liver disease, intolerance to raloxifene or other Allergic reactions

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials